Investigating the role of endoglin in pancreatic cancer
Tumor-intrinsic and paracrine roles of endoglin in pancreatic cancer
This study is looking at how a protein called endoglin affects pancreatic cancer cells, with the goal of finding new ways to improve treatment for patients battling this tough cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10895427 on NIH RePORTER |
What this research studies
This research focuses on pancreatic ductal adenocarcinoma (PDAC), a highly aggressive cancer known for its early spread and resistance to treatment. The study aims to explore how endoglin, a protein involved in blood vessel formation, behaves in pancreatic cancer cells and its impact on tumor growth and drug delivery. By examining different forms of endoglin and their effects on the tumor environment, the researchers hope to uncover new therapeutic targets that could enhance treatment effectiveness for patients with PDAC.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma.
Not a fit: Patients with other types of cancer or those without pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer, improving patient outcomes.
How similar studies have performed: While the specific approach of targeting endoglin in pancreatic cancer is novel, similar strategies targeting angiogenesis have shown promise in other cancer types.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Lee, Nam Y — University of Arizona
- Study coordinator: Lee, Nam Y
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.